Comments
The board of Hester Biosciences is meeting on Wednesday to consider a proposal to raise funds through a qualified institutional placement (QIP) issue. Analysts and traders will closely watch how much the company plans to raise through the QIP issue and the price at which those shares will be allotted. Currently, institutional investors hold around 2 per cent stake in the company. In a recent investors’ meet, the company had said it has plans for capex of ₹19-25 crore this fiscal.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.